PSA test poor predictor of prostate cancer outcome
Le 16 Avril 2007 à 22 h 02 - Reuters - Health
NEW YORK (Reuters Health) - The results of a recent study suggest that the initial prostate-specific antigen (PSA) test and rate of change in PSA levels are poor predictors of aggressive prostate cancer among patients whose cancer has not spread and opt for a "watchful waiting" approach.